Regeneron Pharmaceuticals, Inc. (BIT:1REGN)

Regeneron Pharmaceuticals Statistics

Total Valuation

BIT:1REGN has a market cap or net worth of EUR 57.98 billion. The enterprise value is 44.09 billion.

Market Cap	57.98B
Enterprise Value	44.09B

Important Dates

The last earnings date was Tuesday, October 28, 2025.

Earnings Date	Oct 28, 2025
Ex-Dividend Date	Aug 14, 2025

Share Statistics

Current Share Class	100.78M
Shares Outstanding	n/a
Shares Change (YoY)	-4.39%
Shares Change (QoQ)	-1.29%
Owned by Insiders (%)	3.75%
Owned by Institutions (%)	89.09%
Float	98.57M

Valuation Ratios

The trailing PE ratio is 14.86 and the forward PE ratio is 14.08.

PE Ratio	14.86
Forward PE	14.08
PS Ratio	4.77
PB Ratio	2.20
P/TBV Ratio	2.30
P/FCF Ratio	16.11
P/OCF Ratio	13.42
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.60, with an EV/FCF ratio of 12.25.

EV / Earnings	11.30
EV / Sales	3.57
EV / EBITDA	11.60
EV / EBIT	13.30
EV / FCF	12.25

Financial Position

The company has a current ratio of 4.06, with a Debt / Equity ratio of 0.09.

Current Ratio	4.06
Quick Ratio	3.19
Debt / Equity	0.09
Debt / EBITDA	0.62
Debt / FCF	0.64
Interest Coverage	90.81

Financial Efficiency

Return on equity (ROE) is 15.19% and return on invested capital (ROIC) is 7.27%.

Return on Equity (ROE)	15.19%
Return on Assets (ROA)	6.16%
Return on Invested Capital (ROIC)	7.27%
Return on Capital Employed (ROCE)	10.70%
Revenue Per Employee	797,753
Profits Per Employee	256,328
Employee Count	15,106
Asset Turnover	0.37
Inventory Turnover	2.46

Taxes

In the past 12 months, BIT:1REGN has paid 483.34 million in taxes.

Income Tax	483.34M
Effective Tax Rate	11.02%

Stock Price Statistics

The stock price has decreased by -33.73% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-33.73%
50-Day Moving Average	498.81
200-Day Moving Average	530.24
Relative Strength Index (RSI)	71.91
Average Volume (20 Days)	35

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.76

Income Statement

In the last 12 months, BIT:1REGN had revenue of EUR 12.14 billion and earned 3.90 billion in profits. Earnings per share was 35.45.

Revenue	12.14B
Gross Profit	5.57B
Operating Income	3.26B
Pretax Income	4.39B
Net Income	3.90B
EBITDA	3.71B
EBIT	3.26B
Earnings Per Share (EPS)	35.45

Balance Sheet

The company has 7.20 billion in cash and 2.31 billion in debt, giving a net cash position of 13.66 billion.

Cash & Cash Equivalents	7.20B
Total Debt	2.31B
Net Cash	13.66B
Net Cash Per Share	n/a
Equity (Book Value)	26.39B
Book Value Per Share	256.67
Working Capital	11.55B

Cash Flow

In the last 12 months, operating cash flow was 4.32 billion and capital expenditures -723.86 million, giving a free cash flow of 3.60 billion.

Operating Cash Flow	4.32B
Capital Expenditures	-723.86M
Free Cash Flow	3.60B
FCF Per Share	n/a

Margins

Gross margin is 45.83%, with operating and profit margins of 26.83% and 32.13%.

Gross Margin	45.83%
Operating Margin	26.83%
Pretax Margin	36.11%
Profit Margin	32.13%
EBITDA Margin	30.52%
EBIT Margin	26.83%
FCF Margin	29.63%

Dividends & Yields

This stock pays an annual dividend of 2.38, which amounts to a dividend yield of 0.42%.

Dividend Per Share	2.38
Dividend Yield	0.42%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	6.06%
Buyback Yield	4.39%
Shareholder Yield	4.81%
Earnings Yield	6.73%
FCF Yield	6.21%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BIT:1REGN has an Altman Z-Score of 6.89 and a Piotroski F-Score of 4.

Altman Z-Score	6.89
Piotroski F-Score	4